Results for: drugmaker

Science, patients driving rare disease drug research surge

FTSE ends week with a whimper as commodity stocks fall

Drugmakers Focusing on Rare Disease Treatments

Top U.S. CEOs reaped billions from stock gains in recent years, Reuters...

Insight - Top U.S. CEOs reaped billions from stock gains in recent years,...

Stocks sink on economic worries Dow off 138

Actavis, Warner Chilcott discussing combination

Alkermes rises on depression drug study results

FDA panel backs inhaler drug for lung disease

Tyco: No proof Lilly thieves used security report

Earnings Preview: J&J 1Q to focus on newest drugs

Glaxo, Theravance rise on FDA review of lung drug

Movers roundup: Cardinal Health, Affymax

News Summary: AstraZeneca to cut 1,600 US, UK jobs

Movers roundup: Apple, Suntech

Merck climbs after board OKs study continuation

Hess, True Religion, Ferro are big movers

India rejects Bayer plea against cheap cancer drug

NJ drugmaker pleads to criminal charges

Generic drugmaker Akorn's 4Q profit climbs 54 pct

Warner Chilcott 4Q income rises on reduced costs

Swiss vote on bosses' pay could hit offshore firms

Stocks drop following Fed doubts about stimulus

Ky. attorney general sues GlaxoSmithKline

Ahead of the Bell: Biogen shares keep climbing

AstraZeneca to cut 2,300 jobs in business overhaul

Court: Can drug companies pay to delay generics?

High court struggles over generic drug delay deals

BioMarin will continue Pompe disease drug studies

Novel Amgen virus-vaccine shrinks melanoma tumors

Facebook adds University of Calif chief to board

Drugmakers, Interpol ramp up fight against fakes

FDA panel sees risk in long-used osteoporosis drug

Pfizer painkiller gets longer patent protection

News Summary: Pfizer painkiller patent extended

New WVU center will do human trials for new drugs

Medicines Co, Alnylam Pharma enter alliance

TRC makes mini offer for First Solar shares

Health care among early leaders in the S&P 500

Stocks edge higher, pushing Dow toward 14,000

Next in BP spill saga: civil trial worth billions

Judge OKs $4B BP oil spill criminal settlement

US market heading for best January since the 90s

Oncolytics details broader use for Reolysin

FDA accepts application for new Sanofi MS drug

ImmunoGen slides as analyst cuts rating

Correction: Pfizer-Antidepressant Suit story

News Summary: Surge of rare disease drugs in tests

Pfizer animal health IPO could raise more than $2B

Skechers, Lufkin, Penn Virginia are big movers

Costly blood cancer drug gets PBS listing

Analysis - Fate of $23 billion L'Oreal stake points to future of Nestle

GSK cancer vaccine misses target in melanoma trial

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Rattled by investigations, foreign firms in China beef up compliance

Stocks held back by plunge in factory orders

Lab mice breakthrough offers Alzheimer's hope

J&J 2Q profit jumps on higher sales, lower charges